Editorially Independent Content, Supported with Advertising from: Allergan, Glaukos, Ivantis, New World Medical, Omni Surgical System, Santen
Iqbal Ike K. Ahmed, MD, FRCSC, discusses the management of patients who received a CyPass Micro-Stent (Alcon; no longer on the market) with Jacob Brubaker, MD, and Arsham Sheybani, MD. Dr. Ahmed shares a case of a 70-year-old man who underwent cataract surgery combined with implantation of a CyPass Micro-Stent 3 years ago. Although IOP was 11 mm Hg without medication at a recent visit, the implant appeared to be in contact with the corneal endothelium. Learn more about risk stratification and strategies for management in patients who have this glaucoma device.
CyPass Micro-Stent • Glaucoma • Microinvasive Glaucoma Surgery (MIGS) • MIGS